Does the media refer more to PAHC or AMRX?

In the previous week, Amneal Pharmaceuticals had 5 more articles in the media than Phibro Animal Health. MarketBeat recorded 6 mentions for Amneal Pharmaceuticals and 1 mentions for Phibro Animal Health. Amneal Pharmaceuticals' average media sentiment score of 1.36 beat Phibro Animal Health's score of 1.18 indicating that Amneal Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amneal Pharmaceuticals 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer EWTX or PAHC?

In the previous week, Edgewise Therapeutics had 17 more articles in the media than Phibro Animal Health. MarketBeat recorded 18 mentions for Edgewise Therapeutics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Edgewise Therapeutics' score of -0.24 indicating that Phibro Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 2 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Phibro Animal Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MANE or PAHC?

In the previous week, Veradermics had 2 more articles in the media than Phibro Animal Health. MarketBeat recorded 3 mentions for Veradermics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Veradermics' score of -0.21 indicating that Phibro Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veradermics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Phibro Animal Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PAHC or INDV?

In the previous week, Indivior had 25 more articles in the media than Phibro Animal Health. MarketBeat recorded 26 mentions for Indivior and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Indivior's score of 0.87 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Indivior 7 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor PAHC or DFTX?

In the previous week, Definium Therapeutics had 16 more articles in the media than Phibro Animal Health. MarketBeat recorded 17 mentions for Definium Therapeutics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Definium Therapeutics' score of -0.07 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definium Therapeutics 1 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Phibro Animal Health (PAHC) Competitors

$34.29 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$34.29 +0.00 (+0.01%)

As of 05:53 AM Eastern

Compare

PAHC vs. AMRX, EWTX, MANE, INDV, and DFTX

Should you buy Phibro Animal Health stock or one of its competitors? MarketBeat compares Phibro Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Phibro Animal Health include Amneal Pharmaceuticals (AMRX), Edgewise Therapeutics (EWTX), Veradermics (MANE), Indivior (INDV), and Definium Therapeutics (DFTX). These companies are all part of the "pharmaceuticals" industry.

How does Phibro Animal Health compare to Amneal Pharmaceuticals?

Phibro Animal Health (NASDAQ:PAHC) and Amneal Pharmaceuticals (NASDAQ:AMRX) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Amneal Pharmaceuticals had 5 more articles in the media than Phibro Animal Health. MarketBeat recorded 6 mentions for Amneal Pharmaceuticals and 1 mentions for Phibro Animal Health. Amneal Pharmaceuticals' average media sentiment score of 1.36 beat Phibro Animal Health's score of 1.18 indicating that Amneal Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amneal Pharmaceuticals	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Phibro Animal Health has a net margin of 6.35% compared to Amneal Pharmaceuticals' net margin of 5.05%. Phibro Animal Health's return on equity of 37.14% beat Amneal Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	6.35%	37.14%	8.57%
Amneal Pharmaceuticals	5.05%	-584.46%	7.78%

Phibro Animal Health has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market. Comparatively, Amneal Pharmaceuticals has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Amneal Pharmaceuticals has higher revenue and earnings than Phibro Animal Health. Phibro Animal Health is trading at a lower price-to-earnings ratio than Amneal Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.30B	1.07	$48.26M	$2.33	14.72
Amneal Pharmaceuticals	$3.02B	1.92	$72.06M	$0.49	37.02

99.3% of Phibro Animal Health shares are owned by institutional investors. Comparatively, 31.8% of Amneal Pharmaceuticals shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by company insiders. Comparatively, 17.3% of Amneal Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Phibro Animal Health currently has a consensus price target of $42.50, indicating a potential upside of 23.94%. Amneal Pharmaceuticals has a consensus price target of $17.67, indicating a potential downside of 2.61%. Given Phibro Animal Health's higher possible upside, analysts plainly believe Phibro Animal Health is more favorable than Amneal Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Amneal Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Summary

Amneal Pharmaceuticals beats Phibro Animal Health on 9 of the 16 factors compared between the two stocks.

How does Phibro Animal Health compare to Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ:EWTX) and Phibro Animal Health (NASDAQ:PAHC) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Phibro Animal Health has a net margin of 6.35% compared to Edgewise Therapeutics' net margin of 0.00%. Phibro Animal Health's return on equity of 37.14% beat Edgewise Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edgewise Therapeutics	N/A	-39.01%	-36.96%
Phibro Animal Health	6.35%	37.14%	8.57%

Edgewise Therapeutics presently has a consensus price target of $48.75, suggesting a potential upside of 12.02%. Phibro Animal Health has a consensus price target of $42.50, suggesting a potential upside of 23.94%. Given Phibro Animal Health's higher probable upside, analysts clearly believe Phibro Animal Health is more favorable than Edgewise Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edgewise Therapeutics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Phibro Animal Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

99.3% of Phibro Animal Health shares are held by institutional investors. 21.3% of Edgewise Therapeutics shares are held by insiders. Comparatively, 50.1% of Phibro Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Edgewise Therapeutics has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Phibro Animal Health has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market.

Phibro Animal Health has higher revenue and earnings than Edgewise Therapeutics. Edgewise Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edgewise Therapeutics	N/A	N/A	-$167.79M	-$1.85	N/A
Phibro Animal Health	$1.30B	1.07	$48.26M	$2.33	14.72

In the previous week, Edgewise Therapeutics had 17 more articles in the media than Phibro Animal Health. MarketBeat recorded 18 mentions for Edgewise Therapeutics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Edgewise Therapeutics' score of -0.24 indicating that Phibro Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edgewise Therapeutics	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phibro Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Phibro Animal Health beats Edgewise Therapeutics on 12 of the 16 factors compared between the two stocks.

How does Phibro Animal Health compare to Veradermics?

Veradermics (NYSE:MANE) and Phibro Animal Health (NASDAQ:PAHC) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Phibro Animal Health has a net margin of 6.35% compared to Veradermics' net margin of 0.00%. Phibro Animal Health's return on equity of 37.14% beat Veradermics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veradermics	N/A	N/A	N/A
Phibro Animal Health	6.35%	37.14%	8.57%

99.3% of Phibro Animal Health shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Phibro Animal Health has higher revenue and earnings than Veradermics. Veradermics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veradermics	N/A	N/A	-$70M	-$1.32	N/A
Phibro Animal Health	$1.30B	1.07	$48.26M	$2.33	14.72

Veradermics currently has a consensus target price of $153.00, indicating a potential upside of 34.86%. Phibro Animal Health has a consensus target price of $42.50, indicating a potential upside of 23.94%. Given Veradermics' stronger consensus rating and higher probable upside, research analysts clearly believe Veradermics is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veradermics	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Phibro Animal Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Veradermics had 2 more articles in the media than Phibro Animal Health. MarketBeat recorded 3 mentions for Veradermics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Veradermics' score of -0.21 indicating that Phibro Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veradermics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phibro Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Phibro Animal Health beats Veradermics on 10 of the 14 factors compared between the two stocks.

How does Phibro Animal Health compare to Indivior?

Phibro Animal Health (NASDAQ:PAHC) and Indivior (NASDAQ:INDV) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Phibro Animal Health presently has a consensus price target of $42.50, indicating a potential upside of 23.94%. Indivior has a consensus price target of $45.17, indicating a potential upside of 16.35%. Given Phibro Animal Health's higher possible upside, research analysts clearly believe Phibro Animal Health is more favorable than Indivior.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Indivior	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86

In the previous week, Indivior had 25 more articles in the media than Phibro Animal Health. MarketBeat recorded 26 mentions for Indivior and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Indivior's score of 0.87 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Indivior	7 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Indivior has a net margin of 26.65% compared to Phibro Animal Health's net margin of 6.35%. Phibro Animal Health's return on equity of 37.14% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	6.35%	37.14%	8.57%
Indivior	26.65%	-283.11%	36.85%

Phibro Animal Health has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market. Comparatively, Indivior has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Indivior has higher revenue and earnings than Phibro Animal Health. Indivior is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.30B	1.07	$48.26M	$2.33	14.72
Indivior	$1.33B	3.44	$210M	$2.79	13.91

99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 60.3% of Indivior shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by company insiders. Comparatively, 0.7% of Indivior shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Indivior beats Phibro Animal Health on 10 of the 16 factors compared between the two stocks.

How does Phibro Animal Health compare to Definium Therapeutics?

Phibro Animal Health (NASDAQ:PAHC) and Definium Therapeutics (NASDAQ:DFTX) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Phibro Animal Health has a net margin of 6.35% compared to Definium Therapeutics' net margin of 0.00%. Phibro Animal Health's return on equity of 37.14% beat Definium Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	6.35%	37.14%	8.57%
Definium Therapeutics	N/A	-84.01%	-63.66%

Phibro Animal Health has higher revenue and earnings than Definium Therapeutics. Definium Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.30B	1.07	$48.26M	$2.33	14.72
Definium Therapeutics	N/A	N/A	-$183.79M	-$3.43	N/A

Phibro Animal Health has a beta of 0.46, suggesting that its stock price is 54% less volatile than the broader market. Comparatively, Definium Therapeutics has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Phibro Animal Health currently has a consensus price target of $42.50, indicating a potential upside of 23.94%. Definium Therapeutics has a consensus price target of $55.00, indicating a potential upside of 19.20%. Given Phibro Animal Health's higher probable upside, equities research analysts plainly believe Phibro Animal Health is more favorable than Definium Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definium Therapeutics	1 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.00

99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 27.9% of Definium Therapeutics shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 2.4% of Definium Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Definium Therapeutics had 16 more articles in the media than Phibro Animal Health. MarketBeat recorded 17 mentions for Definium Therapeutics and 1 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.18 beat Definium Therapeutics' score of -0.07 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definium Therapeutics	1 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Phibro Animal Health beats Definium Therapeutics on 11 of the 16 factors compared between the two stocks.

Get Phibro Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PAHC vs. The Competition

Export

Metric	Phibro Animal Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.39B	$11.85B	$7.00B	$12.99B
Dividend Yield	1.40%	2.70%	2.58%	10.20%
P/E Ratio	14.72	790.97	270.58	25.05
Price / Sales	1.07	739.94	598.42	84.08
Price / Cash	10.49	15.12	28.89	37.44
Price / Book	4.86	10.29	11.18	6.43
Net Income	$48.26M	$2.78B	$3.45B	$348.10M
7 Day Performance	-7.70%	2.76%	3.37%	2.66%
1 Month Performance	6.92%	-0.65%	-0.73%	-0.85%
1 Year Performance	22.03%	192.52%	77.30%	23.96%

Phibro Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PAHC Phibro Animal Health	4.8153 of 5 stars	$34.29 flat	$42.50 +23.9%	+22.0%	$1.39B	$1.30B	14.72	2,475	Positive News Gap Up
AMRX Amneal Pharmaceuticals	3.2058 of 5 stars	$18.48 -2.0%	$17.67 -4.4%	+112.4%	$5.90B	$3.02B	37.71	8,500
EWTX Edgewise Therapeutics	2.1221 of 5 stars	$44.71 +16.5%	$48.75 +9.0%	+243.2%	$4.81B	N/A	N/A	60	News Coverage Positive News Earnings Report Analyst Revision High Trading Volume
MANE Veradermics	2.1962 of 5 stars	$106.96 +5.0%	$153.00 +43.0%	N/A	$4.47B	N/A	N/A	19	Gap Down High Trading Volume
INDV Indivior	3.7188 of 5 stars	$36.50 -2.3%	$45.67 +25.1%	+76.5%	$4.45B	$1.24B	18.72	1,051	Trending News Earnings Report Analyst Upgrade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PAHC) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phibro Animal Health (PAHC) Competitors

PAHC vs. AMRX, EWTX, MANE, INDV, and DFTX

How does Phibro Animal Health compare to Amneal Pharmaceuticals?

Summary

How does Phibro Animal Health compare to Edgewise Therapeutics?

Summary

How does Phibro Animal Health compare to Veradermics?

Summary

How does Phibro Animal Health compare to Indivior?

Summary

How does Phibro Animal Health compare to Definium Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PAHC vs. The Competition

Phibro Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Phibro Animal Health (PAHC) Competitors

PAHC vs. AMRX, EWTX, MANE, INDV, and DFTX

How does Phibro Animal Health compare to Amneal Pharmaceuticals?

Does the media refer more to PAHC or AMRX?

Is PAHC or AMRX more profitable?

Which has more risk and volatility, PAHC or AMRX?

Which has preferable earnings and valuation, PAHC or AMRX?

Do institutionals and insiders believe in PAHC or AMRX?

Do analysts rate PAHC or AMRX?

Summary

How does Phibro Animal Health compare to Edgewise Therapeutics?

Is EWTX or PAHC more profitable?

Do analysts recommend EWTX or PAHC?

Do institutionals and insiders have more ownership in EWTX or PAHC?

Which has more risk and volatility, EWTX or PAHC?

Which has higher earnings and valuation, EWTX or PAHC?

Does the media prefer EWTX or PAHC?

Summary

How does Phibro Animal Health compare to Veradermics?

Is MANE or PAHC more profitable?

Do institutionals and insiders hold more shares of MANE or PAHC?

Which has stronger valuation & earnings, MANE or PAHC?

Do analysts rate MANE or PAHC?

Does the media prefer MANE or PAHC?

Summary

How does Phibro Animal Health compare to Indivior?

Do analysts recommend PAHC or INDV?

Does the media refer more to PAHC or INDV?

Is PAHC or INDV more profitable?

Which has more volatility and risk, PAHC or INDV?

Which has stronger earnings & valuation, PAHC or INDV?

Do institutionals & insiders hold more shares of PAHC or INDV?

Summary

How does Phibro Animal Health compare to Definium Therapeutics?

Is PAHC or DFTX more profitable?

Which has stronger valuation and earnings, PAHC or DFTX?

Which has more volatility & risk, PAHC or DFTX?

Do analysts prefer PAHC or DFTX?

Do insiders and institutionals believe in PAHC or DFTX?

Does the media favor PAHC or DFTX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PAHC vs. The Competition

Phibro Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools